Number of Tumor Foci as a Risk Factor for Recurrence in Papillary Thyroid Carcinoma: Does It Improve Predictability?

Simple Summary Thyroid cancer is one of the most common cancers worldwide, and papillary thyroid carcinoma (PTC) comprises over 80% of all thyroid cancers. About 30% of patients with PTC have multifocality, which is useful for recurrence prediction. However, recent studies have suggested that the number of tumors, total tumor diameter, and bilaterality are more powerful predictors of recurrence than multifocality. Herein, we evaluated the effect of these factors on the predictability of recurrence in patients with PTC. Our study of 1288 patients confirmed that the number of tumors, total tumor diameter, and bilaterality could be independent predictors of recurrence even though they did not offer better predictability of recurrence than the prediction model using multifocality. Therefore, a simpler, multifocality-based prediction model would be sufficient for predicting recurrence in patients with PTC. Abstract Multifocality in papillary thyroid carcinoma (PTC) increases the risk of recurrence. Some recent studies have suggested that multifocality-related parameters, such as the number of tumor foci, total tumor diameter (TTD), and bilaterality, are more useful for predicting recurrence than multifocality. However, it is still unclear if these factors can improve the accuracy of the recurrence prediction model. Between 2012 and 2019, 1288 patients with PTC underwent total thyroidectomy at Ewha Womans University Medical Center. The 5-year disease-free survival rate was 91.2% in patients with >3 tumor foci, 95.1% with 3 foci, and 97.6% with 2 foci; conversely, those with a unifocal tumor showed a 5-year recurrence-free survival rate of 98.0%. Cox proportional hazards analysis indicated that the number of tumor foci (HR for >3 foci, 3.214; HR for 3 foci, 2.473), bilaterality (HR, 2.530), or TTD (HR for >3 cm, 5.359; HR for 2–3 cm, 3.584) could be an independent predictor of recurrence. However, models using the number of tumor foci, bilaterality, and TTD did not show better overall predictability of recurrence than models based on multifocality. In conclusion, a simpler prediction model based on multifocality may be sufficient.

[1]  H. Kwon,et al.  Association of Multifocality With Prognosis of Papillary Thyroid Carcinoma: A Systematic Review and Meta-analysis. , 2021, JAMA otolaryngology-- head & neck surgery.

[2]  D. Piciu,et al.  Total Tumor Diameter and Unilateral Multifocality as Independent Predictor Factors for Metastatic Papillary Thyroid Microcarcinoma , 2021, Journal of clinical medicine.

[3]  K. Jung,et al.  Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2018 , 2021, Cancer research and treatment.

[4]  Youben Fan,et al.  Bilateral multifocality, a marker for aggressive disease, is not an independent prognostic factor for papillary thyroid microcarcinoma: A propensity score matching analysis , 2021, Clinical endocrinology.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  M. Schlumberger,et al.  Current practice in patients with differentiated thyroid cancer , 2020, Nature Reviews Endocrinology.

[7]  S. Barollo,et al.  Prognostic significance of the sum of the diameters of single foci in multifocal papillary thyroid cancer: the concept of new-old tumor burden , 2020, Therapeutic advances in endocrinology and metabolism.

[8]  H. Kwon,et al.  The Impact of BRAF Mutation on the Recurrence of Papillary Thyroid Carcinoma: A Meta-Analysis , 2020, Cancers.

[9]  Yong Jiang,et al.  Significance of multifocality in papillary thyroid carcinoma. , 2020, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[10]  L. Wang,et al.  Total tumor diameter: the neglected value in papillary thyroid microcarcinoma , 2019, Journal of Endocrinological Investigation.

[11]  T. Fahey,et al.  Nomogram-Based New Recurrence Predicting System in Early-Stage Papillary Thyroid Cancer , 2019, International journal of endocrinology.

[12]  J. Roh,et al.  Multifocality of papillary thyroid carcinoma as a risk factor for disease recurrence. , 2019, Oral oncology.

[13]  W. Dong,et al.  Time-Varying Pattern of Mortality and Recurrence from Papillary Thyroid Cancer: Lessons from a Long-Term Follow-Up. , 2019, Thyroid : official journal of the American Thyroid Association.

[14]  S. Polat,et al.  Preoperative predictors and prognosis of bilateral multifocal papillary thyroid carcinomas. , 2019, Surgical oncology.

[15]  N. Besic,et al.  Multifocality as independent prognostic factor in papillary thyroid cancer - A multivariate analysis. , 2018, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.

[16]  G. Eslick,et al.  Multifocality as a prognostic factor in thyroid cancer: A meta-analysis. , 2018, International journal of surgery.

[17]  T. Nakazawa,et al.  Clinicopathological Risk Factors for Distant Metastasis in Differentiated Thyroid Carcinoma: A Meta-analysis , 2018, World Journal of Surgery.

[18]  Kaliszewski,et al.  American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer , 2017 .

[19]  Min Zhang,et al.  Clonality analysis of multifocal papillary thyroid carcinoma by using genetic profiles , 2016, The Journal of pathology.

[20]  T. Fahey,et al.  Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients , 2016, Cancer.

[21]  N. Qu,et al.  Predictive factors for recurrence of differentiated thyroid cancer in patients under 21 years of age and a meta-analysis of the current literature , 2016, Tumor Biology.

[22]  Wei-Li Wu,et al.  Bilaterality weighs more than unilateral multifocality in predicting prognosis in papillary thyroid cancer , 2016, Tumor Biology.

[23]  H. Park,et al.  Number of tumor foci as predictor of lateral lymph node metastasis in papillary thyroid carcinoma , 2015, Head & neck.

[24]  Tao Huang,et al.  Multifocality and Total Tumor Diameter Predict Central Neck Lymph Node Metastases in Papillary Thyroid Microcarcinoma , 2013, Annals of Surgical Oncology.

[25]  J. Chung,et al.  Multifocality, But Not Bilaterality, Is a Predictor of Disease Recurrence/Persistence of Papillary Thyroid Carcinoma , 2013, World Journal of Surgery.

[26]  G. Pentheroudakis,et al.  Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.

[27]  C. Hsueh,et al.  High Recurrent Rate of Multicentric Papillary Thyroid Carcinoma , 2009, Annals of Surgical Oncology.